Allotera Therapeutics
Clinical-stage developer of off-the-shelf CAR-T cell therapies, including Sofi-cel for aggressive T-cell cancers.
$35MSeries C extension and venture debt
ParticipantB
BioGenerator
Activity from announced rounds
Activity in this selectionitalian-founders-fund-f7b9d627
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $35M 1 disclosed · full round size, not this investor’s share